EUVIMEDEUVIMED entdecken
Open Access

Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals

Alison Schaefer, Bing Yang, Holly A Schroeder, Dimple Harit, Mike S Humphry, Jacques Ravel, Samuel K Lai

Acta Biomaterialia · 2023

DOI: 10.1016/j.actbio.2023.07.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Alison Schaefer und 6 weiteren Autor:innen. Beteiligte Einrichtung: UNC/NCSU Joint Department of Biomedical Engineering, Chapel Hill, NC 27519, USA. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, David and Lucile Packard Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In addition to direct neutralization and other classical effector functions, IgG possesses a little recognized and thus under-utilized effector function at mucosal surfaces: Fc-mucin bonds enable IgG to trap viruses in mucus. Due to the paucity of envelope glycoproteins that limits the number of IgG that can bind HIV, it remains poorly understood whether IgG-mucin interactions can effectively immobilize HIV in human cervicovaginal mucus (CVM). Here, we obtained 54 fresh, undiluted CVM specimens from 17 different women, and employed high-resolution multiple particle tracking to quantify the mobility of fluorescent HIV virus-like-particles in CVM treated with various HIV-specific IgG. We observed consistent and effective trapping of HIV by broadly neutralizing antibodies (VRC01, PGT121, and 2F5) in a subset of women. While trapping efficacy was not affected by the menstrual cycle, it was positively correlated with appreciable L. Crispatus populations in the microbiome, and negatively correlated with appreciable L. Iners or G. Vaginalis populations. Our work demonstrates for the first time that IgG-mucin crosslinking is capable of reinforcing the mucosal barrier against HIV, and motivates further investigation of passive immunization against vaginal transmission of STIs. STATEMENT OF SIGNIFICANCE: HIV transmission in women primarily occurs vaginally, yet the 3-way interactions between mucins and HIV virions mediated by HIV-binding antibodies in cervicovaginal mucus (CVM) is not well understood. While IgG-Fc possess weak affinity to mucins that trap virus/IgG complexes in mucus, the effectiveness against HIV remains unclear, due to the low number of virion-bound IgG. Here, we discovered that IgG can trap HIV consistently in CVM from select individuals regardless of their birth control status or menstrual cycle phase. IgG-mediated trapping of HIV was moderately associated with microbiome composition. These results suggest that IgG-mucin interactions could potentially reduce HIV transmission and highlight the importance of mucosal secretions in antibody-mediated prevention of HIV and other sexually transmitted infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsHumansFemaleCervix UteriBroadly Neutralizing AntibodiesMucusImmunoglobulin GMucins

Stichwörter der Autor:innen

AntibodiesDiffusionHIVIgGMucosal immunologyPassive immunization

Substanzen

Broadly Neutralizing AntibodiesImmunoglobulin GMucins

Autor:innen und Institutionen

  • UNC/NCSU Joint Department of Biomedical Engineering, Chapel Hill, NC 27519, USA.
  • Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27519,USA.
  • Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • UNC/NCSU Joint Department of Biomedical Engineering, Chapel Hill, NC 27519, USA; Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27519,USA; Depar…

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • David and Lucile Packard Foundation

Zitieren

APA

Schaefer, A., Yang, B., Schroeder, H. A., Harit, D., Humphry, M. S., Ravel, J., & Lai, S. K. (2023). Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.07.031

Vancouver

Schaefer A, Yang B, Schroeder HA, Harit D, Humphry MS, Ravel J, et al. Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.07.031

BibTeX
@article{Schaefer2023,
  author = {Schaefer, Alison and Yang, Bing and Schroeder, Holly A and Harit, Dimple and Humphry, Mike S and Ravel, Jacques and Lai, Samuel K},
  title = {Broadly neutralizing antibodies consistently trap HIV-1 in fresh cervicovaginal mucus from select individuals},
  journal = {Acta Biomaterialia},
  year = {2023},
  doi = {10.1016/j.actbio.2023.07.031}
}
Kostenlos starten →